Antibody Innovation & Technology Platform Partnerships
Driving cutting-edge translational biology research with platform-compatible antibodies
True innovation is collaborative. Our partnerships empower scientists to tackle complex scientific challenges and drive biological breakthroughs across the entire research continuum by enhancing workflow efficiencies, offering greater flexibility, and increasing reproducibility. We forge fruitful partnerships with scientists and entrepreneurs from both the non-profit and corporate sectors, and look forward to new collaborations that advance scientific discovery.
Leica Biosystems
Fully automated multiplex IHC protocols increase accuracy and reduce hands-on time up to 70%.
Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions, responsible for the BOND RX Fully Automated Research Stainer. Together, CST® SignalStar® mIHC assays and BOND RX and RXm fully automated spatial biology protocols significantly reduce hands-on time for scientists, generating 8-plex IHC images in just two days, delivering imaging assay results 70% faster than other multiplex IHC methods.
Leica Microsystems
Over 200 CST antibodies work on the Cell DIVE Imaging System, providing enhanced flexibility and workflow efficiency.
Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. As an open multiplexing system, Cell DIVE offers unparalleled flexibility in antibody selection, allowing researchers to design custom antibody biomarker panels. Knowing that select CST antibodies have been tested and verified using the Cell DIVE multiplexing workflow gives researchers the ability to move forward with confidence.
Biocare Medical
Validated staining protocols reduce hands-on time and increase assay accuracy, reliability, and reproducibility.
Biocare Medical is an innovator in designing and delivering advanced automated immunohistochemistry instruments. The ONCORE Pro X Automated Slide Staining System is a compact, bench-top, open platform that simplifies and automates slide staining for Immunohistochemistry (IHC), Fluorescence In Situ Hybridization (FISH), and In Situ Hybridization (ISH) applications. When paired with SignalStar mIHC’s powerful signal amplification, customizable panel options, and rigorously validated CST antibodies, researchers can trust that their results will be accurate, reliable, and highly reproducible.
Visiopharm
Confidently interrogate cellular interactions in the tumor microenvironment with streamlined biomarker discovery and AI-driven analysis.
Visiopharm empowers researchers with AI-driven image analysis tools that transform how tissue samples are interpreted—bringing clarity, speed, and reproducibility to complex biological questions. By integrating the advanced SignalStar mIHC assay from CST with Visiopharm’s Phenoplex software, scientists gain an unprecedented ability to visualize and quantify cellular interactions within diseased tissues—driving innovative translational research and therapeutic development.
ZEISS Microscopy
Fully automated, HDR imaging with AI-enabled detection accelerates spatial biology discoveries using SignalStar Multiplex IHC.
ZEISS Microscopy revolutionizes imaging and workflow solutions for the Biotech and Pharma industries, enabling advanced tissue multiplexing with precision and efficiency. The Axioscan 7 spatial biology automated slide scanner, featuring an integrated data analysis platform, delivers seamless compatibility and unmatched flexibility with the SignalStar mIHC assay, enabling researchers to accelerate their journey from sample to discovery with confidence.
Ready to empower discovery with trusted biological tools? Collaborate with us! Fill out the form below to work with us—we’re excited to learn more about the opportunity and get started.
Contact us using the form below for:
- Collaborations and Partnerships
- In-Licensing and Sourcing
- OEM and Antibody Supply
- Out-Licensing